ReviewIntensive care medicine2026
Feeding the injured brain: nutrients, dose, timing, and monitoring.
Review in Intensive care medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Patterns of Enteral Feeding, Feeding Intolerance, and Mortality in Traumatic Brain Injury: An Observational Study.Clinics and practice · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nutrition is a key component of the management of neurocritically ill patients. The healthy brain accounts for up to 25% of total resting energy expenditure (REE), and after injury the brain faces inflammation, altered glucose metabolism, and catabolic stress. This review outlines the evolving science and current practice of nutrition in neurocritical illness, emphasizing pathophysiology, metabolic phases, and individualized strategies. Enteral nutrition remains the preferred route, with early, low-dose initiation within 24-48 h generally recommended. Feeding intolerance, aspiration risk, and altered gastrointestinal motility are common barriers. Parenteral nutrition may be warranted when enteral nutrition is contraindicated or insufficient; however, early initiation of target feeding, independent of the enteral or parenteral route of administration, has shown harm in general ICU populations and remains underexplored in neurocritically ill patients. The role of timing to start feeding, energy and protein dosing, micronutrient supplementation, and metabolic monitoring via indirect calorimetry is discussed, with recent trials questioning traditional targets. Emerging concepts include the ketogenic diet, exogenous lactate, and immunonutrition, all of which aim to optimize recovery and reduce secondary brain injury. Despite promising mechanistic rationale, robust neurocritical-specific data are lacking. Personalized nutrition based on metabolic phenotyping and real-time monitoring to optimize neurocritical nutrition requires further validation. Ultimately, nutritional care in neurocritical settings might benefit from a multidisciplinary integrated approach. Rather than supportive care alone, nutrition could be viewed as a modifiable therapeutic intervention with the potential to influence neurological recovery and long-term outcomes.
Indexed as
Identifiers
41801269What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.